Bicara Therapeutics Inc. Common Stock
BCAX
$18.56-1.28%
End of day · as of Sep 30, 2026, 3:25 AM ET
Mkt cap
$1.51B
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-1.73
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Use this BCAX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BCAX income, balance, and cash tables.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company in the Healthcare sector.
Latest cached Bicara Therapeutics Inc. Common Stock (BCAX) net income for FY2025 was -$137.9M. Statements: https://lician.com/financials/bcax
Bicara Therapeutics Inc. Common Stock (BCAX) market capitalization is $1.51B on the latest cached snapshot.
Bicara Therapeutics Inc. Common Stock (BCAX) cached previous close $18.80; day range $18.51 – $19.39; volume 599,779. Session quote: https://lician.com/quote/bcax
Bicara Therapeutics Inc. Common Stock (BCAX) latest cached earnings event is "BCAX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BCAX filing is 8-K · Aug 25, 2026. Filings: https://lician.com/sec/bcax